Intrauterine infusion of hyaluronic acid gel in women with Asherman's syndrome

the hyaluronic acid gel in women with Asherman's syndrome

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110509006420N22

Enrollment

Registered

2020-03-19

Start date

2019-12-21

Completion date

Unknown

Last updated

2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asherman Syndrome. Intrauterine synechiae

Interventions

Intervention 1: Intervention group: For this study, a questionnaire was designed which include demographic data, Lab & check-up results before and after treatment. After getting consent, data will be

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: All patients with Asherman's syndrome

Exclusion criteria

Exclusion criteria: Severe cervical stenosis Mullerian anomaly systemic disorders

Design outcomes

Primary

Measure	Time frame
Adhesion scoring. Timepoint: 4 to 6 weeks after hysteroscopy. Method of measurement: With hysteroscopy & ASRM score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Eftekhar

Yazd University of Medical Sciences

eftekharmaryam@yahoo.com+98 35 3824 7085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026